Stock Information
Contineum Therapeutics Inc (CTNM)
Ticker Symbol: CTNM
Exchange: NASDAQ
Sector: Pharmaceuticals
Market Cap: $392.21 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -2.1997
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -29.75%
Latest News
-
Contineum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fri, May 1, 2026 4:06 PM
-
Contineum Therapeutics Stock Edges Higher As PIPE-791 Pain Data Clears Safety Bar
Fri, May 1, 2026 10:45 AM
-
Contineum Therapeutics : PIPE-791 Phase 1b Chronic Pain Trial Topline Data Supplemental Information
Thu, Apr 30, 2026 5:48 PM
-
Contineum Therapeutics Announces Its Phase 1b Study Of PIPE-791 Meets Primary Endpoint By Demonstrating At Least 30% Reduction In Chronic Pain
Thu, Apr 30, 2026 4:27 PM
-
Contineum Therapeutics Reports Positive Topline Data From Its Exploratory PIPE-791 Phase 1b Trial in Chronic Pain
Thu, Apr 30, 2026 4:06 PM
Key Financials
Financial data not available
